Zentek Ltd. (CVE:ZEN - Get Free Report) shot up 17.7% on Wednesday . The company traded as high as C$2.48 and last traded at C$2.39. 260,536 shares changed hands during mid-day trading, an increase of 528% from the average session volume of 41,460 shares. The stock had previously closed at C$2.03.
Zentek Price Performance
The firm has a 50-day moving average of C$1.51 and a 200-day moving average of C$1.44. The stock has a market cap of C$245.53 million, a PE ratio of -22.55 and a beta of 0.77. The company has a debt-to-equity ratio of 4.97, a current ratio of 2.06 and a quick ratio of 7.59.
About Zentek
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
